Invention Grant
- Patent Title: Broadly neutralizing glycan-dependent 8ANC195 antibody variants that bind to an epitope spanning both HIV-1 Env subunits
-
Application No.: US15115547Application Date: 2015-01-30
-
Publication No.: US10421803B2Publication Date: 2019-09-24
- Inventor: Michel Nussenzweig , Pamela J. Bjorkman , Louise Scharf , Johannes Scheid
- Applicant: The Rockefeller University , California Institute of Technology
- Applicant Address: US NY New York US CA Pasadena
- Assignee: The Rockefeller University,California Institute of Technology
- Current Assignee: The Rockefeller University,California Institute of Technology
- Current Assignee Address: US NY New York US CA Pasadena
- Agency: Fox Rothschild LLP
- International Application: PCT/US2015/013924 WO 20150130
- International Announcement: WO2015/117008 WO 20150806
- Main IPC: C07K16/10
- IPC: C07K16/10 ; A61K39/42 ; A61P31/18 ; A61K39/21 ; C07K14/005 ; G01N33/569
Abstract:
The present invention relates to broadly neutralizing anti-HIV-1 antibodies and isolated antigens. Also disclosed are related methods and compositions.
Public/Granted literature
- US20180171001A1 Broadly Neutralizing Anti-HIV Antibodies and Epitope Therefor Public/Granted day:2018-06-21
Information query
